SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-004083
Filing Date
2015-05-12
Accepted
2015-05-12 16:47:42
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20150331.htm 10-Q 1477375
2 EX-31.1 xene-ex311_20150331169.htm EX-31.1 10267
3 EX-31.2 xene-ex312_20150331170.htm EX-31.2 10527
4 EX-32.1 xene-ex321_20150331171.htm EX-32.1 8465
5 EX-32.2 xene-ex322_20150331172.htm EX-32.2 8344
  Complete submission text file 0001564590-15-004083.txt   3752133

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xene-20150331.xml EX-101.INS 354785
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20150331.xsd EX-101.SCH 23503
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20150331_cal.xml EX-101.CAL 26910
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20150331_def.xml EX-101.DEF 40482
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20150331_lab.xml EX-101.LAB 175566
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20150331_pre.xml EX-101.PRE 125921
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 15855067
SIC: 2834 Pharmaceutical Preparations